Nika Pharmaceuticals, Inc (NIKA): Total Assets
$21.0K
As of 2025-12-31
$5.3K
As of 2026-09-30
+189.7%
3-year compound annual growth
+67.1%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.0K | +17.1% | 2026-03-25, Balance as of period end |
| 2024-12-31 | $17.9K | -8.5% | 2026-03-25, Balance as of period end |
| 2023-12-31 | $19.6K | n/m | 2025-03-31, Balance as of period end |
| 2022-12-31 | $864 | +116.5% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $399 | -75.2% | 2023-04-10, Balance as of period end |
| 2020-12-31 | $1.6K | n/a | 2022-03-03, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Nika Pharmaceuticals, Inc (NIKA) | 2025-12-31 | $21.0K | +17.1% |
| CNBX Pharmaceuticals Inc. (CNBX) | 2025-08-31 | $18.4K | -41.3% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| Cell Source, Inc. (CLCS) | 2024-12-31 | $286.5K | +46.8% |
| Polomar Health Services, Inc. (PMHS) | 2025-12-31 | $390.0K | -96.1% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $422.5K | +50.3% |
| Trafalgar International, Inc. (TRFA) | 2025-12-31 | $815 | -98.6% |
Compare NIKA, CNBX, SKVI, BDPT side by side · Screen every company in Pharmaceutical Preparations ↗